相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
Sergio Giralt et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years
Cynthia Huisman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: Revised definitions to predict survival
Daniel Weisdorf et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
Mohamed Sorror et al.
CANCER (2008)
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
Katayoun Rezvani et al.
BLOOD (2008)
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival
Mary Eapen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
Christoph Kahl et al.
BLOOD (2007)
Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning - is there still an upper age limit? A focus on myeloid neoplasia
J. Finke et al.
LEUKEMIA (2007)
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
Elihu Estey et al.
BLOOD (2007)
Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors
J. M. Hows et al.
BONE MARROW TRANSPLANTATION (2006)
A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy
Steven Knapper et al.
BLOOD (2006)
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using BLA-identical sibling donors in myelodysplastic syndromes
Rodrigo Martino et al.
BLOOD (2006)
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors
U Hegenbart et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
EBMT activity survey 2004 and changes in disease indication over the past 15 years
A. Gratwohl et al.
BONE MARROW TRANSPLANTATION (2006)
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
M Aoudjhane et al.
LEUKEMIA (2005)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older
V Gupta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies
P Corradini et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age
EP Alyea et al.
BLOOD (2005)
Comorbidity indices in hematopoietic stem cell transplantation: a new report card
J Alamo et al.
BONE MARROW TRANSPLANTATION (2005)
Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens
GL Banna et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation
M de Lima et al.
BLOOD (2004)
Stem cell transplantation-harnessing of graft-versus-malignancy
JH Antin
CURRENT OPINION IN HEMATOLOGY (2003)
Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia
H Bertz et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Generalised linear models for correlated pseudo-observations, with applications to multi-state models
PK Andersen et al.
BIOMETRIKA (2003)
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
D Grimwade et al.
BLOOD (2001)
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
PA McSweeney et al.
BLOOD (2001)
Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy
R Champlin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
